RNAC Operating Cash Flow Growth
Cartesian Therapeutics Inc · Operating Cash Flow Growth
RNAC Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-124.14%period ending
RNAC TTM Cash from Operations YoY % (12.38% → -124.14%)
Year-over-year change
High-resolution chart · PNG
RNAC operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -124.1397% | |
| -136.4102% | |
| -212.33% | |
| -58.2437% | |
| 46.0104% | |
| 47.0701% | |
| 53.7265% | |
| -0.5891% | |
| -140.3426% | |
| -104.3775% | |
| -61.7432% | |
| 22.4777% | |
| 60.5734% | |
| 52.5361% | |
| 47.6152% | |
| -41.6621% | |
| -264.9822% | |
| -274.5137% | |
| -273.1086% | |
| -223.6438% | |
| 184.6476% | |
| 180.3068% | |
| 167.8157% | |
| 157.0195% | |
| 15.4974% | |
| 35.0027% | |
| 13.0593% | |
| 13.1641% | |
| 3.8862% | |
| -31.6417% | |
| -13.6903% | |
| -56.2723% | |
| -110.0898% | |
| -101.8685% | |
| -164.3753% | |
| -30.9221% | |
| 4.0827% | |
| 10.4504% | |
| 12.3759% |